Literature DB >> 15722242

Catheter-based pH monitoring: use in evaluation of gastroesophageal reflux disease symptoms (on and off therapy).

Kenneth R DeVault1.   

Abstract

Tube-based ambulatory pH testing has rapidly evolved in the past 3 decades to become the standard by which other diagnostic approaches to gastroesophageal reflux disease are judged. Acid exposure 5 cm above the manometrically determined lower esophageal sphincter is the standard for documentation of pathologic acid exposure of the distal esophagus. Proximal esophageal or hypopharyngeal monitoring is an evolving technique that may shed light on patients with supraesophageal symptoms. The ability to simultaneously monitor esophageal and gastric acidity (usually in patients with persistent symptoms despite therapy) is another advantage of this technique. Whether the new system that allows simultaneous pH and impedance monitoring and the system that uses an implantable tubeless monitoring capsule will supplant this older but well-established technology remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722242     DOI: 10.1016/j.giec.2004.10.003

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  2 in total

1.  Technical problems produced by the Bravo pH test in nonerosive reflux disease patients.

Authors:  Andrés de Hoyos; Edgar Alain Esparza
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Endoscopic pH monitoring for patients with suspected or refractory gastroesophageal reflux disease.

Authors:  B G Turner; J R Saltzman; L Hua; R Maurer; Natan Feldman; D L Carr-Locke; R Burakoff; J J Liu
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.